Protocol Exchange

Author Information

Subject Terms

Keywords

Abstract

Introduction & Materials

Procedures

Outcomes

Conflicting Financial Interests

Associated Publications

Supplementary Files

Figures

Ferdinand Haller

Cornelia Prehn

Jerzy Adamski

Figure 1

Figure 2

Figure 3

Quantification of steroids in human and mouse plasma using online solid phase extraction coupled to liquid chromatography tandem mass spectrometry

Steroids are powerful signalling molecules regulating a variety of physiological processes such as cell proliferation, cell differentiation, and reproduction. Variations in steroid concentrations may hint at hormonal imbalances or metabolic disorders that allow for a diagnosis of human diseases. The measurement of steroid hormone concentrations is relevant to basic research as well as clinical sciences. For example, the systematic generation of mouse mutants has led to a need for comprehensive phenotyping. As these mouse models may bear defects that affect steroid synthesis or homeostasis, knowledge of the mouse steroid metabolome could help to identify these mutants and connect phenotypes to their molecular cause 1.Metabolic characterisation of a large human cohort recently led to the discovery of associations between phenotype, metabolome, and genotype as shown by us 2. To expand our knowledge of the metabolome to other substance classes, a high-throughput, robust, sensitive and specific steroid phenotyping method is required.


For several years, immunoassays have been the standard method for measuring steroid concentrations. Recently, liquid chromatography tandem mass spectrometry methods for steroid analysis have been developed that combine the advantages of immunoassays \(i.e. sensitivity) with the specificity of mass spectrometry 3. 


This protocol describes a high-throughput method to analyze several different steroids in plasma. By using online-SPE coupled to LC-MS/MS, six different steroids \(androstenedione, testosterone, cortisone, cortisol, progesterone, 17OH-progesterone) are readily quantifiable in human plasma, while three steroids \(androstenedione, testosterone, corticosterone) can be quantified in mouse plasma. The method requires a minimum of hands-on time by the experimenter while simultaneously providing concentrations of several interesting steroids.

d8-Corticosterone \(C/D/N Isotopes)


d4-Cortisol \(C/D/N Isotopes)


d9-Progesterone \(C/D/N Isotopes)


13C2-Testosterone \(Cambridge Isotope Laboratories)





17OH-Progesterone \(Sigma)


Androstenedione \(Steraloids)


Cortisol \(Sigma)


Cortisone \(Sigma)


Progesterone \(Sigma)


Testosterone \(Sigma)





Acetonitrile \(HPLC grade, Roth)


Methanol \(HPLC grade, Merck)


ZnSO4 \(Merck)

Allure Biphenyl column 3 µm; 50 mm x 2.1 mm \(Restek)


Oasis HLB column 15 µm; 20 mm x 2.1 mm \(Waters)





4000 Q TRAP triple quadrupole mass spectrometer with a Turbo V source \(Applied Biosystems)


Analyst software 1.4.2 \(Applied Biosystems)





HPLC system consisting of two HPLC pumps \(one of them a binary gradient pump), an autosampler, a column oven with a built-in 6 port switching valve, and matching controlling unit e.g. Shimadzu LC-20AB, LC-20AD, SIL-20AC, CTO-20, and CBM-20A \(Shimadzu)

A. Sampling of blood


1. collect blood from subject \(human or mouse)
 2. prepare EDTA plasma
 3. store plasma at -80 °C before use
 


B. Preparation of precipitation agent containing internal standards


1. dissolve 50 g/L ZnSO4 in water
 2. mix ZnSO4 solution 1:1 with methanol \(v/v) to get the precipitation agent
 3. dilute internal standards in precipitation agent: 13C2-Testosterone 1.5 ng/mL \(final concentration); d4-Cortisol 7.5 ng/mL \(final concentration); d9-Progesterone 1.5 ng/mL \(final concentration); d8-Corticosterone 15 ng/mL \(final concentration)
 4. place at -20 °C before use
 


C. Sample preparation


1. mix 50 µL plasma with 100 µL precipitation agent
 2. vortex mix for 60 s
 3. incubate at 4 °C for 30 min with continuous shaking
 4. centrifuge at 14000 rpm at 4 °C for 10 min
 5. transfer supernatant to deep well plate for measurement
 


D. Chromatographic separation of samples


1. prepare solvents for chromatography; methanol:water \(5:95) for solid phase extraction; acetonitrile:water:formic acid \(10:90:0.1) as solvent A for gradient run; acetonitrile:formic acid \(100:0.1) as solvent B for gradient run 
 2. equilibrate chromatographic system with solvents \(gradient flow rate is 0.5 mL/min; online-SPE flow rate is 3 mL/min
 3. inject 80 µL of supernatant via autosampler
 4. apply gradient and valve switching information \(sample is enriched on online-SPE column and eluted in backflush onto the analytical column) from table 1
 


E. MS/MS analysis


1. measure samples in positive mode using an ESI source
 2. set ion source parameters to CUR = 20; CAD = 6; IS = 4500; TEM = 600; GS1 = 40; GS2 = 55
 3. use the multiple reaction monitoring \(MRM) mass transitions given in table 1
 4. for calibration run standards in the following concentrations: 0.1, 0.19, 0.39, 0.78, 1.56, 3.13, 6.25, 12.5, 25 ng/mL for androstenedione, testosterone, progesterone, and 17OH-progesterone; 0.98, 1.95, 3.91, 7.81, 15.63, 31.25, 62.5, 125, 250 ng/mL for cortisone, cortisol, and corticosterone
 5. also run appropriate blanks \(steroid stripped plasma) and quality control samples
 6. evaluate results using Analyst 1.4.2 software \(Applied Biosystems)

For preparation of 100 samples: hands-on time 2-3 h


For measurement of 100 samples: about 8.5 h \(no hands-on time, performed by autosampler and LC-MS/MS system)

Chromatography solvents and the precipitation agent should be prepared fresh for each run. Pipetting steps before addition of internal standards are critical and should be performed as exactly as possible.

Typical results for human and mouse plasma are shown in Figures 1 and 2, respectively.

1. V. Gailus-Durner, H. Fuchs, L. Becker et al., Nat Methods 2 \(6), 403 \(2005).
  2. T. Illig, C. Gieger, G. Zhai et al., Nat Genet \(2009).
  3. F. Z. Stanczyk, J. S. Lee, and R. J. Santen, Cancer Epidemiol Biomarkers Prev 16 \(9), 1713 \(2007).

Method Article

Ferdinand Haller, Cornelia Prehn, Jerzy Adamski

Ferdinand Haller

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

Cornelia Prehn

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

Jerzy Adamski

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

DOI:

10.1038/nprot.2010.22

Download PDF

License:

This work is licensed under a CC BY-NC 3.0 License. Read Full License

Figures

Introduction

Reagents

Equipment

Procedure

Timing

Critical Steps

Anticipated Results

References

Comments

Version History

CURRENT STATUS: Posted

Version 1

No community comments so far

Metrics

Comments: 0

HTML Views: ...

Method Article

Ferdinand Haller, Cornelia Prehn, Jerzy Adamski

Ferdinand Haller

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

Cornelia Prehn

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

Jerzy Adamski

Institute for Experimental Genetics, Helmholtz Zentrum Muenchen

Badges

Peer Review Timeline

Version History

CURRENT STATUS: Posted

Version 1

No community comments so far

Metrics

Metrics

Comments: 0

HTML Views: ...

DOI & PDF

DOI:

10.1038/nprot.2010.22

Download PDF

License

License:

This work is licensed under a CC BY-NC 3.0 License. Read Full License

Declarations

Figures

Introduction

Reagents

Equipment

Procedure

Timing

Critical Steps

Anticipated Results

References

Comments

Related Articles

Privacy Policy

Terms of Service